Orexo eyes opioid use disorder app launch before year-end

Sweden’s Orexo says its opioid use disorder (OUD) digital therapeutic – now christened Modia – is on course for a launch before the end of the year in the US.

Orexo partners with Lyfebulb to study addiction during pande...

With drinking and drug use said to be spiking during the pandemic, Orexo has teamed up with US organisation Lyfebulb to research how the crisis is affecting people with addicti

Orexo partners with Gaia on digital opioid abuse therapeutic

FDA clears Pear/Sandoz app for opioid use disorder

A second mobile app developed by Pear Therapeutics to help opioid use disorder patients who have a more successful response to therapy has been given a green light by the FDA.

Novartis and Pear to develop substance use digital therapeut...

Novartis is set to develop and commercialise a range of digital therapeutics for patients with substance and opioid use disorders as it expands its work with Pear Therapeutics through a dea